Showing results (211-220 of 314) with videos related to

Sort By:
Pageof 32
Analytical Chemistry|October 22, 2025
Characterization of Burned Soil Organic Matter via Sequential Solvent Extractions and 21 T FT-ICR Mass Spectrometry with Electrospray and Atmospheric Pressure PhotoionizationHolly K Roth, Amy M McKenna, Martha L Aguilera, et al.
Preventive Medicine Reports|November 15, 2022
Sentinel surveillance of SARS-CoV-2 rates and equity impacts using labor and delivery patients in Phoenix, ArizonaCaitlyn J Linehan, Trisalyn Nelson, Celeste V Bailey, et al.
The Journal of Infectious Diseases|February 11, 2000
Mutations in the protein kinase-binding domain of the NS5A protein in patients infected with hepatitis C virus type 1a are associated with treatment responseC Sarrazin, T Berg, J H Lee, et al.
Journal of Medical Virology|February 15, 2001
Comparative sequence analysis of the core- and NS5-region of hepatitis C virus from tumor and adjacent non-tumor tissueB Rüster, S Zeuzem, V Krump-Konvalinkova, et al.
Hepatology (Baltimore, Md.)|April 16, 1998
Quantification of the initial decline of serum hepatitis C virus RNA and response to interferon alfaS Zeuzem, J H Lee, A Franke, et al.
Journal of Virology|April 27, 2007
Inhibition of the alpha/beta interferon response by mouse hepatitis virus at multiple levelsJessica K Roth-Cross, Luis Martínez-Sobrido, Erin P Scott, et al.
Developmental Science|April 12, 2011
Object recognition in Williams syndrome: uneven ventral stream activationKirsten O'Hearn, Jennifer K Roth, Susan M Courtney, et al.
Archives of Disease in Childhood|March 1, 1993
Operation for gastro-oesophageal reflux associated with severe mental retardationL Spitz, K Roth, E M Kiely, et al.
Journal of Hepatology|October 6, 1997
Dynamics of hepatitis B virus infection in vivoS Zeuzem, R A de Man, P Honkoop, et al.
Journal of Hepatology|July 16, 1999
Improved correlation between multiple mutations within the NS5A region and virological response in European patients chronically infected with hepatitis C virus type 1b undergoing combination therapyC Sarrazin, T Berg, J H Lee, et al.
Pageof 32